Volume 29, Number 6—June 2023
Research
Increased Incidence of Legionellosis after Improved Diagnostic Methods, New Zealand, 2000–2020
Table 1
Category | 2000–2009 |
2010–2020 |
Comparison of 2 periods, IRR (95% CI) | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
No. cases | Crude rate | ASR† (95% CI) | IRR (95% CI) | No. cases | Crude rate | ASR† (95% CI) | IRR (95% CI) | ||||
Age group, y | |||||||||||
Total | 643 | 1.6 | 1.5 (1.4–1.6) |
NA | 1,985 | 3.9 | 3.8 (3.6–3.9) |
NA | 2.5 (2.3–2.7) | ||
<1–39 | 46 | 0.2 | NA | Referent | 99 | 0.4 | NA | Referent | 1.7 (1.2–2.9) | ||
40–59 | 219 | 1.9 | NA | 9.1 (6.6–12.5) |
619 | 5.0 | NA | 12.8 (10.3–15.8) |
2.5 (2.1–2.9) | ||
>60 |
378 |
4.5 |
NA |
21.9 (16.1–29.7) |
1,267 |
11.8 |
NA |
32.8 (26.7–40.2) |
2.6 (2.3–2.9) |
||
Sex | |||||||||||
M | 383 | 1.9 | 1.9 (1.7–2.11) |
1.7 (1.4–2.0) |
1,265 | 5.0 | 5.0 (4.7–5.2) |
1.9 (1.8–2.1) |
2.6 (2.3–2. 9) | ||
F | 254 | 1.2 | 1.1 (1.0–1.3) |
Referent | 720 | 2.7 | 3.0 (2.4–2.8) |
Referent | 2.3 (2.0–2.6) | ||
Unknown |
6 |
NA |
0 |
NA |
|||||||
Ethnicity | |||||||||||
European | 517 | 2.3 | 2.1 (1.9–2.3) |
Referent | 1,620 | 4.5 | 3.9 (3.7–4.1) |
Referent | 1.85 (1.67–2.04) | ||
Māori | 27 | 0.5 | 0.7 (0.4–1.1) |
0.35 (0.22–0.55) |
149 | 1.7 | 2.8 (1.4–3.3) |
0.73 (0.61–0.88) |
3.89 (2.42–6.25) | ||
Pacific Peoples | 13 | 0.6 | 0.7 (0.3–1.1) |
0.32 (0.17–0.58) |
72 | 1.7 | 3.1 (2.3–3.9) |
0.80 (0.62–1.03) |
4.63 (2.42–8.88) | ||
Other | 17 | 0.2 | 0.2 (0.1–0.4) |
0.11 (0.07–0.19) |
93 | 1.1 | 1.7 (1.4–2.1) |
0.45 (0.36–0.56) |
7.46 (4.31–12.9) | ||
Unknown |
69 |
NA |
51 |
NA |
|||||||
Laboratory status | |||||||||||
Confirmed | 537 | 1.3 | 0.9 (0.8–0.9) |
Referent | 1,700 | 3.3 | 2.4 (2.2–2.5) |
Referent | 2.7 (2.5–3.0) | ||
Probable |
106 |
0.2 |
0.2 (0.1–0.2) |
0.2 (0.2–0.23) |
285 |
0.6 |
0.4 (0.3–0.4) |
0.2 (0.1–0.2) |
2.2 (1.7–2.7) |
||
L. pneumophila | |||||||||||
Total | 256 | 6.2 | NA | NA | 527 | 11.2 | NA | NA | 1.80 (1.57–1.94) | ||
<1–39 | 9 | 0.3 | Referent | 58 | 0.8 | Referent | 2.67 (2.31–2.86) | ||||
40–59 | 58 | 1.0 | 1.41 (0.97–1.73) |
196 | 2.9 | 2.85 (2.19–3.12) |
2.90 (2.50–3.04) | ||||
>60 |
189 |
3.2 |
13.6 (9.42–16.5) |
273 |
4.9 |
5.15 (3.99–5.63) |
1.53 (1.33–1.88) |
||||
L. longbeachae | |||||||||||
Total | 161 | 3.9 | NA | NA | 1,062 | 22.6 | NA | NA | 5.79 (5.49–6.12) | ||
1–39 | 5 | 0.1 | Referent | 39 | 0.6 | Referent | 2.00 (1.96–2.29) | ||||
40–59 | 56 | 1.0 | 2.60 (1.70–3.26) |
284 | 3.8 | 1.76 (1.41–1.85) |
3.80 (3.68–3.96) | ||||
>60 |
98 |
2.4 |
7.50 (5.00–9.42) |
739 |
14.6 |
11.02 (8.86–11.51) |
6.10 (6.26–6.67) |
||||
Other species | |||||||||||
Total | 87 | 2.1 | NA | NA | 251 | 5.3 | NA | NA | 2.52 (2.16–2.89) | ||
<1–39 | 11 | 0.1 | Referent | 50 | 0.7 | Referent | 7.00 (6.43–7.69) | ||||
40–59 | 35 | 0.5 | 3.24 (1.94–4.56) |
79 | 1.2 | 2.21 (1.55–2.64) |
2.40 (1.90–2.50) | ||||
>60 | 41 | 0.9 | 4.30 (2.58–5.99) |
122 | 2.3 | 4.56 (3.26–5.34) |
2.56 (2.35–2.83) | ||||
Unknown | 139 | NA | 145 | NA |
*Crude rate is cases per 100,000 population. ASR, age-standardized rate; IRR, incidence rate ratio; NA, not applicable. †Age standardized to the New Zealand population age structure at the 2013 census.
Page created: April 12, 2023
Page updated: May 17, 2023
Page reviewed: May 17, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.